BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 24521297)

  • 1. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.
    Gao H; Yang Z; Cao S; Xiong Y; Zhang S; Pang Z; Jiang X
    Biomaterials; 2014 Feb; 35(7):2374-82. PubMed ID: 24342723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma targeting and anti-glioma effect of interleukin 13 peptide and RGD peptide dual functionalized nanoparticles.
    Gao H; Hu Y; Xiong Y; Zhang S; Yang J; Yu L; Jiang X
    Curr Pharm Biotechnol; 2014; 14(13):1118-26. PubMed ID: 24016266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
    J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
    Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
    Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
    Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
    Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
    Feng X; Yao J; Gao X; Jing Y; Kang T; Jiang D; Jiang T; Feng J; Zhu Q; Jiang X; Chen J
    ACS Appl Mater Interfaces; 2015 Dec; 7(50):27885-99. PubMed ID: 26619329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
    Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
    Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.
    Wang B; Lv L; Wang Z; Zhao Y; Wu L; Fang X; Xu Q; Xin H
    Biomaterials; 2014 Jul; 35(22):5897-907. PubMed ID: 24743033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
    Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z
    Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy.
    Feng X; Gao X; Kang T; Jiang D; Yao J; Jing Y; Song Q; Jiang X; Liang J; Chen J
    Bioconjug Chem; 2015 Aug; 26(8):1850-61. PubMed ID: 26222392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
    Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
    Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
    Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
    Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
    Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a
    Zhang M; Lu L; Ying M; Ruan H; Wang X; Wang H; Chai Z; Wang S; Zhan C; Pan J; Lu W
    Mol Pharm; 2018 Jun; 15(6):2437-2447. PubMed ID: 29734808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.